Literature DB >> 22890715

Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.

M A Burmeister1, D P Bracy, F D James, R M Holt, J Ayala, E M King, D H Wasserman, D J Drucker, J E Ayala.   

Abstract

In response to oral glucose, glucagon-like peptide-1 receptor (Glp1r) knockout (Glp1r−/−) mice become hyperglycaemic due to impaired insulin secretion. Exercise also induces hyperglycaemia in Glp1r−/− mice. In contrast to oral glucose, exercise decreases insulin secretion. This implies that exercise-induced hyperglycaemia in Glp1r−/− mice results from the loss of a non-insulinotropic effect mediated by the Glp1r. Muscle glucose uptake (MGU) is normal in exercising Glp1r−/− mice. Thus, we hypothesize that exercise-induced hyperglycaemia in Glp1r−/− mice is due to excessive hepatic glucose production (HGP). Wild-type (Glp1r+/+) and Glp1r−/− mice implanted with venous and arterial catheters underwent treadmill exercise or remained sedentary for 30 min. [3-3H]glucose was used to estimate rates of glucose appearance (Ra), an index of HGP, and disappearance (Rd). 2[14C]deoxyglucose was used to assess MGU. Glp1r−/− mice displayed exercise-induced hyperglycaemia due to an excessive increase in Ra but normal Rd and MGU. Exercise-induced glucagon levels were ∼2-fold higher in Glp1r−/− mice, resulting in a ∼2-fold higher glucagon:insulin ratio. Since inhibition of the central Glp1r stimulates HGP, we tested whether intracerebroventricular (ICV) infusion of the Glp1r antagonist exendin(9–39) (Ex9) in Glp1r+/+ mice would result in exercise-induced hyperglycaemia. ICV Ex9 did not enhance glucose levels or HGP during exercise, suggesting that glucoregulatory effects of Glp1 during exercise are mediated via the pancreatic Glp1r. In conclusion, functional disruption of the Glp1r results in exercise-induced hyperglycaemia associated with an excessive increase in glucagon secretion and HGP. These results suggest an essential role for basal Glp1r signalling in the suppression of alpha cell secretion during exercise.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890715      PMCID: PMC3497575          DOI: 10.1113/jphysiol.2012.234914

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  61 in total

1.  Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling.

Authors:  N J MacLusky; S Cook; L Scrocchi; J Shin; J Kim; F Vaccarino; S L Asa; D J Drucker
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

2.  Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men.

Authors:  A Shalev; R Ninnis; U Keller
Journal:  Horm Res       Date:  1998

3.  Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.

Authors:  A Vella; P Shah; A S Reed; A S Adkins; R Basu; R A Rizza
Journal:  Diabetologia       Date:  2002-09-05       Impact factor: 10.122

4.  Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes.

Authors:  G S Meneilly; C H McIntosh; R A Pederson; J F Habener; R Gingerich; J M Egan; D T Finegood; D Elahi
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

5.  Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.

Authors:  B Ahrén; G Pacini
Journal:  Am J Physiol       Date:  1999-12

6.  Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Authors:  Josephine M Egan; Graydon S Meneilly; Joel F Habener; Dariush Elahi
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

Authors:  Tina Vilsbøll; Thure Krarup; Sten Madsbad; Jens J Holst
Journal:  Regul Pept       Date:  2003-07-15

8.  CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.

Authors:  Kimberly P Kinzig; David A D'Alessio; James P Herman; Randall R Sakai; Torsten P Vahl; Helmer F Figueiredo; Erin K Murphy; Randy J Seeley; Helmer F Figueredo
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

9.  Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.

Authors:  R W Gelling; X Q Du; D S Dichmann; J Romer; H Huang; L Cui; S Obici; B Tang; J J Holst; C Fledelius; P B Johansen; L Rossetti; L A Jelicks; P Serup; E Nishimura; M J Charron
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

10.  Appetite suppression and weight reduction by a centrally active aminosterol.

Authors:  Rexford S Ahima; Hiralben R Patel; Nobuhiko Takahashi; Yong Qi; Stanley M Hileman; Michael A Zasloff
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  1 in total

1.  Calcium co-ingestion augments postprandial glucose-dependent insulinotropic peptide(1-42), glucagon-like peptide-1 and insulin concentrations in humans.

Authors:  Javier T Gonzalez; Emma J Stevenson
Journal:  Eur J Nutr       Date:  2013-05-21       Impact factor: 5.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.